Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Biophytis Sa ADR
(NQ:
BPTS
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Apr 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Biophytis Sa ADR
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
12 Health Care Stocks Moving In Thursday's After-Market Session
February 03, 2022
Gainers Cidara Therapeutics (NASDAQ:CDTX)...
Via
Benzinga
Mid-Afternoon Market Update: Dow Dips 350 Points; Bank of England Hikes Interest Rates
February 03, 2022
US stocks remained under pressure on Thursday after Meta Platforms, Inc. (NASDAQ: FB) reported weaker-than-expected earnings for its fourth quarter and issued a weak forecast.
Via
Benzinga
Mid-Day Market Update: Nasdaq Down 2%; Biophytis Shares Spike Higher
February 03, 2022
US stocks traded lower after Meta Platforms, Inc. (NASDAQ: FB) reported weaker-than-expected earnings for its fourth quarter and issued a weak forecast.
Via
Benzinga
32 Stocks Moving In Thursday's Mid-Day Session
February 03, 2022
Gainers Bon Natural Life Limited (NASDAQ: BON) climbed 24.2% to $4.11 following FY21 results. Bon Natural Life reported FY21 earnings of $0.68 per share on sales of $25.5 million...
Via
Benzinga
Why Are Biophytis Shares Trading Higher During Premarket Trading?
February 03, 2022
Biophytis SA (NASDAQ: BPTS) has received approval fro
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
February 03, 2022
Gainers SOC Telemed (NASDAQ:TLMD) shares increased by 338.2% to $2.82 during Thursday's pre-market session. The market value of their outstanding shares is at $284.5...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
February 03, 2022
Good morning, trader! We're starting off another day of trading with a breakdown of the biggest pre-market stock movers for Thursday!
Via
InvestorPlace
Biophytis Received Approval from ANVISA (Brazil) to Give Access to Sarconeos (BIO101) to Hospitalized COVID-19 Patients through an Expanded Access Program
February 03, 2022
- ANVISA (Brazilian Health Authority) approved Biophytis' Expanded Access Program (EAP) for hospitalized patients with severe COVID-19 and mechanically ventilated in Intensive Care Unit - Sarconeos...
From
Biophytis
Via
AccessWire
Exposures
COVID-19
Stocks That Hit 52-Week Lows On Monday
January 31, 2022
On Monday morning, 49 companies achieved new lows for the year. Points of Interest From Today's 52-Week Lows: The largest company by market cap to hit a new 52-...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
January 31, 2022
Gainers Calithera Biosciences (NASDAQ:CALA) shares moved upwards by 42.8% to $0.6 during Monday's regular session. As of 12:30 EST, Calithera Biosciences's stock...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
January 21, 2022
Gainers Biophytis (NASDAQ:BPTS) shares rose 12.3% to $5.28 during Friday's regular session. The market value of their outstanding shares is at $68.0 million. Intra-...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
January 13, 2022
Gainers Rockwell Medical (NASDAQ:RMTI) st...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
December 30, 2021
Gainers Kiora Pharmaceuticals (NASDAQ:KPRX
Via
Benzinga
Biophytis Announces the Drawing of the Last Tranche of ORNANE Under the 2020 Atlas Contract for €3 Million
December 22, 2021
PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / December 22, 2021 / Biophytis SA (NASDAQ:BPTS)(Euronext Growth Paris:ALBPS), a clinical-stage biotechnology company focused on the development of...
From
Biophytis
Via
AccessWire
Topics
Bonds
Exposures
Debt Markets
Biophytis to Meet with FDA to Advance Sarconeos (BIO101) Development in Sarcopenia from Phase 2 to Phase 3
December 16, 2021
- Following Phase2b/SARA-INT clinically meaningful results, Biophytis is starting first regulatory activities to advance from Phase 2 to Phase 3 development - A Type B/End-of-Phase 2 meeting is planned...
From
Biophytis
Via
AccessWire
Exposures
COVID-19
Product Safety
12 Health Care Stocks Moving In Monday's Intraday Session
December 13, 2021
Gainers Arena Pharmaceuticals (NASDAQ:ARNA...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
December 02, 2021
Gainers Biofrontera (NASDAQ:BFRI) shares ...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 30, 2021
Gainers Cumberland (NASDAQ:CPIX) shares rose 91.81% to $4.22 during Tuesday's pre-market session. The company's market cap stands at $62.4 million. First Wave...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
November 30, 2021
Good morning, investor! We're starting off Tuesday with a breakdown of the biggest pre-market stock movers you need to know about!
Via
InvestorPlace
Exposures
Product Safety
12 Health Care Stocks Moving In Monday's Intraday Session
November 29, 2021
Gainers Krystal Biotech (NASDAQ:KRYS) shares moved upwards by 118.21% to $86.87 during Monday's regular session. Krystal Biotech's stock is trading at a volume of...
Via
Benzinga
Biophytis Obtains a New 10M€ Loan Structure With Kreos Capital
November 22, 2021
PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / November 22, 2021 / Biophytis SA (NASDAQ:BPTS)(Euronext Growth Paris: ALBPS) (the "Company" or "Biophytis"), a clinical-stage biotechnology company...
From
Biophytis
Via
AccessWire
Topics
Bonds
Regulatory Compliance
Exposures
COVID-19
Debt Markets
Legal
12 Health Care Stocks Moving In Friday's After-Market Session
November 19, 2021
Gainers CASI Pharmaceuticals (NASDAQ:CASI
Via
Benzinga
Biophytis To Restart Recruitment In US Centers For COVID-19 Trial
November 15, 2021
Biophytis SA (NASDAQ: BPTS) has announced that patient recruitment in the U.S., paused in May while waiting for results of the Interim Analysis 2, has restarted. ...
Via
Benzinga
Exposures
COVID-19
12 Health Care Stocks Moving In Monday's Intraday Session
November 15, 2021
Gainers Tricida (NASDAQ:TCDA) shares rose...
Via
Benzinga
Biophytis Announces US Centers to Restart Recruitment for the COVA Phase 2-3 Study with Sarconeos (BIO101) in COVID-19
November 15, 2021
PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / November 15, 2021 / Biophytis SA (NasdaqCM:BPTS, Euronext Growth Paris: ALBPS) (the "Company" or "Biophytis"), a clinical-stage biotechnology company...
From
Biophytis
Via
AccessWire
Topics
Regulatory Compliance
Exposures
COVID-19
Legal
Product Safety
12 Health Care Stocks Moving In Thursday's After-Market Session
November 04, 2021
Gainers Assertio Holdings (NASDAQ:ASRT) ...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 02, 2021
Gainers Bone Biologics (NASDAQ:BBLG) shares rose 33.57% to $7.32 during Tuesday's pre-market session. The company's market cap stands at $224.5 million. Artelo...
Via
Benzinga
24 Stocks Moving in Tuesday's Pre-Market Session
November 02, 2021
Gainers Baosheng Media Group Holdings Limited (NASDAQ: BAOS) rose 119% to $3.43 in pre-market trading after declining 3% on Monday. The company, last month, swung to a loss...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
November 01, 2021
Gainers Biophytis (NASDAQ:BPTS) shares mo...
Via
Benzinga
Biophytis to Report Restated Financial Statements for Previous Periods and as of June 30, 2021
October 29, 2021
PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / October 29, 2021 / Biophytis SA (NASDAQ:BPTS)(Euronext Growth Paris:ALBPS) (the "Company" or "Biophytis"), a clinical-stage biotechnology company focused...
From
Biophytis
Via
AccessWire
Topics
Bonds
Derivatives
Regulatory Compliance
Exposures
COVID-19
Debt Markets
Derivatives
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.